Research programme: endocan inhibitors - EndotisAlternative Names: Endocan inhibitors research programme - Endotis; EP 16; EP 208
Latest Information Update: 03 Oct 2015
At a glance
- Originator Endotis Pharma
- Class Monoclonal antibodies; Recombinant proteins
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Jun 2004 Preclinical trials in Cancer in France (unspecified route)